INCOME STATEMENT (Quarterly GAAP In millions $) |
(Mar 31 2024) I. Quarter |
(Dec 31 2023) IV. Quarter |
(Sep 30 2023) III. Quarter |
(Jun 30 2023) II. Quarter |
(Mar 31 2023) I. Quarter |
Revenue From Contract With Customer Excluding Assessed Tax |
20.21 |
|
39.67 |
35.26 |
34.88 |
Other Revenue |
-0.05 |
|
-0.09 |
-0.37 |
0.00 |
Total Revenue |
20.17 |
32.93 |
39.58 |
34.90 |
34.88 |
Cost of Goods and Services Sold |
7.00 |
16.22 |
20.00 |
20.00 |
15.78 |
Gross
Profit |
13.17 |
16.71 |
19.58 |
14.90 |
19.10 |
Selling, Administration, Marketing |
13.21 |
20.21 |
20.92 |
20.56 |
20.23 |
Depriciation & Amortization |
- |
- |
- |
- |
- |
Research and Development Expense |
- |
0.81 |
0.85 |
1.71 |
1.25 |
Impairment of Intangible Assets, Finite-lived |
- |
0.28 |
- |
22.79 |
16.66 |
Other operatinig exp. /-income |
5.23 |
3.65 |
4.33 |
6.28 |
5.96 |
Unusual Expense /-Income |
- |
- |
- |
- |
- |
Total operating costs including COS |
25.45 |
41.17 |
46.10 |
71.33 |
59.87 |
Operating income/-loss
|
-5.28 |
-8.24 |
-6.52 |
-36.44 |
-25.00 |
Other Deductions / - Income |
Interest expense |
0.32 |
0.35 |
0.36 |
0.35 |
0.37 |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
0.32 |
0.35 |
0.36 |
0.35 |
0.37 |
Loss/ -Gain on Investment |
- |
- |
- |
- |
- |
Foreign Currency Transaction (Gain) Loss |
- |
- |
- |
- |
- |
Allowances, Health Care Trust Fund And Other |
- |
- |
- |
- |
- |
Unexpected (Gain) Loss |
- |
- |
- |
- |
- |
Other loss/ -income |
-0.51 |
0.13 |
-0.70 |
-2.02 |
0.05 |
Fair Value Adjustment Of Warrants |
- |
- |
- |
- |
0.35 |
Total costs & expenses |
25.26 |
41.64 |
45.76 |
69.66 |
60.65 |
Income /-loss before income taxes |
-5.09 |
-8.72 |
-6.18 |
-34.76 |
-25.77 |
Income taxes expenses/-benefit |
0.07 |
-1.01 |
0.09 |
0.03 |
0.03 |
Income after income taxes |
-5.16 |
-7.71 |
-6.27 |
-34.79 |
-25.80 |
Net income/-loss
of other equity |
- |
0.00 |
- |
0.00 |
- |
Income/-loss
from cont. Ops. |
-5.16 |
-7.71 |
-6.27 |
-34.79 |
-25.80 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
-5.16 |
-7.71 |
-6.27 |
-34.79 |
-25.80 |
Noncontrolling interests |
- |
- |
- |
- |
- |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
-5.16 |
-7.71 |
-6.27 |
-34.79 |
-25.80 |
EBIT |
-4.77 |
-8.37 |
-5.82 |
-34.42 |
-25.40 |
EBITD |
-4.34 |
-7.90 |
-5.37 |
-33.21 |
-23.64 |
EBITDA |
-4.34 |
-7.90 |
-5.37 |
-33.21 |
-23.64 |